title: Chronic depression as a model disease for cerebral aging.
abstract: Conceptualizations of the underlying neurobiology of major depression have changed their focus from dysfunctions of neurotransmission to dysfunctions of neurogenesis and neuroprotection. The "neurogenesis hypothesis of depression" posits that changes in the rate of neurogenesis are the underlying mechanism in the pathology and treatment of major depression. Stress, neuroinflammation, dysfunctional insulin regulation, oxidative stress, and alterations in neurotrophic factors possibly contribute to the development of depression. The influence of antidepressant therapies, namely pharmacotherapy and neuroprotectants, on cellular plasticity are summarized. A dysfunction of complex neuronal networks as a consequence of neural degeneration in neuropsychiatric diseases has led to the application of deep brain stimulation. We discuss the way depression seen in the light of the neurogenesis hypothesis can be used as a model disease for cerebral aging. A common pathological mechanism in depression and cerebral aging-a dysfunction of neuroprotection and neurogenesis-is discussed. This has implications for new treatment methods.
authors.affiliation: Department of Psychiatry and Psychotherapy, University Hospital, Bonn, Germany.
authors.forename: Bettina H
authors.initials: BH
authors.lastname: Bewernick
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Schlaepfer
mesh_terms: D000375:Aging / Q000187:drug effects / Q000473:pathology*; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology*; D002908:Chronic Disease; D046690:Deep Brain Stimulation; D003863:Depression / Q000473:pathology* / Q000628:therapy; D006801:Humans; D055495:Neurogenesis / Q000187:drug effects; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology
keywords: Alzheimer's disease; Parkinson's disease; antidepressant therapy; cerebral aging; deep brain stimulation; depression; neurodegeneration; neuroinflammation; neuroplasticity; neuroprotectant; plasticity